Taiki Hakozaki

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Small Cell Lung Cancer

Brain Metastases

Epidermal Growth Factor Receptor

Top Venues

Thoracic cancer

Future oncology (London, England)

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy, Meriem Messaoudene
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer. Current oncology (Toronto, Ont.) 30 (11) (2023)
Yuto Terashima, Taiki Hakozaki, Yuji Uehara, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike, Yukio Hosomi
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy. International journal of clinical oncology (2023)
Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, Yusuke Okuma, Shohei Nakamura, Danielle Moreau-Amaru, Taichi Tamura, Yukio Hosomi, Haruko Takeyama, Corentin Richard, Masahito Hosokawa, Bertrand Routy
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis. Cancers 14 (21) (2022)
Yuji Uehara, Kageaki Watanabe, Taiki Hakozaki, Makiko Yomota, Yukio Hosomi
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations. Thoracic cancer 13 (11) (2022)
Yuto Terashima, Taiki Hakozaki, Susumu Takeuchi, Yukio Hosomi
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report. Thoracic cancer 13 (23) (2022)
Shigemasa Takamizawa, Yusuke Okuma, Yasuhiro Kato, Taiki Hakozaki, Shingo Kitagawa, Yoshitaka Zenke
First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status. Future oncology (London, England) (2021)
Fyza Y Shaikh, James R White, Joell J Gills, Taiki Hakozaki, Corentin Richard, Bertrand Routy, Yusuke Okuma, Mykhaylo Usyk, Abhishek Pandey, Jeffrey S Weber, Jiyoung Ahn, Evan J Lipson, Jarushka Naidoo, Drew M Pardoll, Cynthia L Sears
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Shingo Kitagawa, Taiki Hakozaki, Rui Kitadai, Yukio Hosomi
Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review. Thoracic cancer 11 (7) (2020)
Taiki Hakozaki, Corentin Richard, Arielle Elkrief, Yukio Hosomi, Myriam Benlaïfaoui, Iris Mimpen, Safae Terrisse, Lisa Derosa, Laurence Zitvogel, Bertrand Routy, Yusuke Okuma
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer. Cancer immunology research 8 (10) (2020)